Occurrence of esophageal granular cell tumors in the Netherlands between 1988 and 1994

Citation
Jh. Voskuil et al., Occurrence of esophageal granular cell tumors in the Netherlands between 1988 and 1994, DIG DIS SCI, 46(8), 2001, pp. 1610-1614
Citations number
12
Categorie Soggetti
Gastroenerology and Hepatology","da verificare
Journal title
DIGESTIVE DISEASES AND SCIENCES
ISSN journal
01632116 → ACNP
Volume
46
Issue
8
Year of publication
2001
Pages
1610 - 1614
Database
ISI
SICI code
0163-2116(200108)46:8<1610:OOEGCT>2.0.ZU;2-K
Abstract
Granular cell tumors (GCT) of the esophagus are rare. The tumor is generall y beleived to be of neurogenic origin and shows a malignant course in 2-4% of cases. No unanimity has been reached regarding the management of this tu mor. A national survey was conducted on the incidence of GCT of the esophag us, related symptoms, management, and follow-up. A national survey was perf ormed on all newly registered esophageal GCTs in the PALGA system (Dutch re gister of all pathology diagnoses) for seven consecutive years (1988-1994). Fifty-two new cases (17 men, 35 women; median age 46 years, range 22-77 ye ars) were registered. In 44 cases clinical data could be obtained (survey r esponse 85%). The majority of the GCTs were solitary (42/44) and localized in the distal esophagus (33/44). At endoscopy the size of the tumor was est imated at <5 mm. in 50%, 5-10 mm in 25%, and 10-30 mm in 18%. Most patients (40/44) presented with nonspecific gastrointestinal symptoms, only four ha d dysphagia (tumor size >1 cm). No malignancies were reported. Management o f the tumor included excisional biopsy (1/44), endoscopic polypectomy (3/44 ), and surgical excision (1/44). Endoscopic follow up (1-60 months) in 16 o ut of 17 patients left untreated showed either a stable tumor size or regre ssion of the tumor. In one case with multiple GCT's a slight tumor growth w as seen after a follow-up period of 48 months. Esophageal GCTs in the Nethe rlands are rare, and mostly diagnosed incidentally. Most patients suffer fr om nonspecific symptoms; dysphagia occurs only with tumors >1 cm. The usual clinical course of esophageal GCTs is benign. Patients without dysphagia p robably do not require routine endoscopic follow-up, provided they are inst ructed to contact their physician, once dysphagia develops.